BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18668392)

  • 1. Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide.
    Shannon E; Noveck R; Sandoval F; Kamath B
    Immunopharmacol Immunotoxicol; 2008; 30(3):447-57. PubMed ID: 18668392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-alpha.
    Shannon EJ; Sandoval F; Krahenbuhl JL
    Immunopharmacology; 1997 Apr; 36(1):9-15. PubMed ID: 9129992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone.
    Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I
    Immunol Lett; 1999 Jun; 68(2-3):325-32. PubMed ID: 10424439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells.
    Rowland TL; McHugh SM; Deighton J; Dearman RJ; Ewan PW; Kimber I
    Immunopharmacology; 1998 Jul; 40(1):11-20. PubMed ID: 9776474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction.
    Tadesse A; Abebe M; Bizuneh E; Mulugeta W; Aseffa A; Shannon EJ
    Immunopharmacol Immunotoxicol; 2006; 28(3):431-41. PubMed ID: 16997792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
    Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
    Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells.
    Shannon EJ; Sandoval F
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):59-72. PubMed ID: 8683039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
    Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
    Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
    Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
    Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.
    Mazzoccoli L; Cadoso SH; Amarante GW; de Souza MV; Domingues R; Machado MA; de Almeida MV; Teixeira HC
    Biomed Pharmacother; 2012 Jul; 66(5):323-9. PubMed ID: 22770990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide inhibited the synthesis of IgM and IgG whereas Thalidomide+Dexamethasone and Dexamethasone alone acted as co-stimulants with pokeweed and enhanced their synthesis.
    Shannon EJ; Sandoval F
    Int Immunopharmacol; 2010 Apr; 10(4):487-92. PubMed ID: 20123041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line.
    Kim YS; Kim JS; Jung HC; Song IS
    Mol Cells; 2004 Apr; 17(2):210-6. PubMed ID: 15179032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.
    Chaulet C; Croix C; Alagille D; Normand S; Delwail A; Favot L; Lecron JC; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1019-22. PubMed ID: 21215621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory assays to study structure-activity relationships of thalidomide.
    Shannon EJ; Morales MJ; Sandoval F
    Immunopharmacology; 1997 Jan; 35(3):203-12. PubMed ID: 9043933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: Role for peripheral TNFα, IL-1β and IL-10.
    Carvalho TT; Borghi SM; Pinho-Ribeiro FA; Mizokami SS; Cunha TM; Ferreira SH; Cunha FQ; Casagrande R; Verri WA
    Eur J Pharmacol; 2015 Feb; 749():62-72. PubMed ID: 25584775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meprin-alpha metalloproteases enhance lipopolysaccharide-stimulated production of tumour necrosis factor-alpha and interleukin-1beta in peripheral blood mononuclear cells via activation of NF-kappaB.
    Gao P; Si LY
    Regul Pept; 2010 Feb; 160(1-3):99-105. PubMed ID: 20026360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of soluble receptor for tumor necrosis factor alpha induced by M. leprae or LPS from human mononuclear cells.
    Santos DO; Lorré K; de Boer M; Van Heuverswyn H
    Nihon Hansenbyo Gakkai Zasshi; 1999 Nov; 68(3):185-93. PubMed ID: 10659614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity.
    Tamandl D; Bahrami M; Wessner B; Weigel G; Ploder M; Fürst W; Roth E; Boltz-Nitulescu G; Spittler A
    Shock; 2003 Sep; 20(3):224-9. PubMed ID: 12923493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner.
    Payvandi F; Wu L; Haley M; Schafer PH; Zhang LH; Chen RS; Muller GW; Stirling DI
    Cell Immunol; 2004 Aug; 230(2):81-8. PubMed ID: 15598423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.
    Corral LG; Muller GW; Moreira AL; Chen Y; Wu M; Stirling D; Kaplan G
    Mol Med; 1996 Jul; 2(4):506-15. PubMed ID: 8827720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.